Friday, December 11, 2020
Moderna begins study of COVID-19 vaccine in adolescents | Reuters
Moderna begins study of COVID-19 vaccine in adolescents | Reuters: Moderna Inc said on Thursday it had dosed the first participants in a mid-to-late stage study testing its COVID-19 vaccine candidate in adolescents aged 12 to less than 18, and aims for data ahead of the 2021 school year.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment